Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are safe. Companies don’t have to tell the FDA about those decisions, and they don’t have to list all ingredients on their…
By MATTHEW HOLT A long time ago in a different country, there was a landslide election from a population looking for change. And change they got. Americans had been campaigning for national health care since 1917. There had been failures in 1933 and 1946 and 1961. But in 1965 they got it. Sort of. But…
The answer is ‘yes’ according to a paper by Borrelli et al. (2025). The authors use annual Medicare Star Rating health plan performance for Medicare Advantage-Part D (MAPD) plans over the past decade (2015 to 2024). They find that: For plans achieving at least 4 stars on the medication adherence measures, 70%-74% of them also…
Employers should review their contracts, conduct claims analyses and more to meet their fiduciary responsibility, according to one expert. The post 7 Things Employers Should Be Doing to Fulfill Their Fiduciary Duty appeared first on MedCity News.
Experts say the fallout from HHS’ restructuring could set public health efforts back by decades by dismantling critical infrastructure. It’s also important to note that these changes cast serious doubt on the future of interoperability, pointed out Jason Prestinario, CEO of data platform Particle Health. The post What Does HHS’ Restructuring Mean for Interoperability In…
Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics. The post Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect appeared first on MedCity News.
This analysis provides data on women experiencing intimate partner violence (IPV) and reports on a range of health topics affecting women who experienced IPV in the past five years, including their health care needs and use, barriers, and mental health.
Health insurance claims are a growing headache for providers; many say their employers could do more to help them address the daily demands of insurers The post How Healthcare Employers Can Do More To Help Providers Manage Payer Frustration appeared first on MedCity News.
A very small percentage of health outcomes are tied to direct healthcare activities. The non-medical factors, conditions in which people are born, grow, live, and work in, more often than not, impact health outcomes more than the clinical care they receive. The post A Reality Check on SDOH: Challenges We Can’t Ignore appeared first on…
This brief examines the main points raised in an HHS report reviewing evidence on gender affirming care concerning psychotherapy. It focuses on recommendations around “exploratory therapy,” which could include gender conversion practices, as well as the current legal and policy environment across the country regarding this practice.